YARD-FORCE
26.6.2024 21:01:29 CEST | Business Wire | Press release
Yard Force is excited to introduce the LM C37B Cordless Lawn Mower, a high-performance solution designed to tackle larger lawns with ease. With a cutting width of 37 cm, a powerful dual-battery system, and a range of practical features, the LM C37B ensures your lawn remains neat and tidy with minimal effort. The Yard Force LM C37B Cordless Lawn Mower is now available for purchase on Amazon.de here.
Key Features of the Yard Force LM C37B Cordless Lawn Mower:
- Extensive Cutting Area: The LM C37B is designed to effortlessly manage larger lawns, capable of mowing up to an impressive 450 square meters. This makes it the ideal choice for homeowners with medium to large lawns who want to maintain a pristine garden with minimal effort.
- Powerful Dual-Battery System: Powered by a robust 20V 2.5Ah dual-battery system, this lawn mower ensures you have ample energy to complete your mowing tasks. The package includes a 2A charger for fast and convenient recharging, so you can get back to work in no time.
- Efficient Brushless Motor: At the heart of the LM C37B is a highly efficient brushless motor. This advanced technology not only provides superior performance but also extends the mower's lifespan, making it a reliable and durable addition to your garden tools.
- Versatile Cutting Width and Height: With a generous cutting width of 37 cm and a central cutting height adjustment ranging from 25 mm to 75 mm, this lawn mower offers great flexibility. Whether you prefer a short, manicured lawn or a longer, natural look, you can easily achieve your desired grass length.
- Practical Features for Easy Lawn Care: The LM C37B comes with a 40L grass bag that provides ample space for grass clippings, reducing the need for frequent emptying. Additionally, the one-button height adjustment system makes it incredibly easy to switch between different grass lengths, allowing you to tailor your mowing experience to the needs of your lawn.
Customer Popularity in Germany:
The Yard Force LM C37B Cordless Lawn Mower has quickly gained popularity in the German market for its power, efficiency, and versatility. Available for purchase on Amazon.de, this lawn mower continues to receive positive reviews and high demand from satisfied customers.
For more information and to purchase the Yard Force LM C37B Cordless Lawn Mower, visit Amazon.de.
About Yard Force:
Yard Force is a global leader in innovative garden tools and outdoor power equipment. Known for our dedication to quality, performance, and customer satisfaction, we strive to enhance the outdoor experience with our cutting-edge products. Yard Force is committed to delivering reliable and efficient solutions that meet the diverse needs of our customers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240626165559/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom